EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

BACKGROUND: Limited effectiveness of therapeutic agents targeting epidermal growth factor receptor (EGFR) in clinical trials using unselected ovarian cancer patients has prompted efforts to more effectively stratify patients who might best benefit from these therapies. A series of studies that have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genes Cancer
Main Authors: Mehner, Christine, Oberg, Ann L., Goergen, Krista M., Kalli, Kimberly R., Maurer, Matthew J., Nassar, Aziza, Goode, Ellen L., Keeney, Gary L., Jatoi, Aminah, Radisky, Derek C., Radisky, Evette S.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511892/
https://ncbi.nlm.nih.gov/pubmed/28740577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/genesandcancer.142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados